Business Description
Samjin Pharmaceutical Co Ltd
ISIN : KR7005500004
Share Class Description:
XKRX:005500: Ordinary SharesCompare
Compare
Traded in other countries / regions
005500.Korea IPO Date
1988-06-18Description
Samjin Pharmaceutical Co Ltd is a part of the healthcare sector in Korea. The company functions as a pharmaceutical product manufacturer addressing severe diseases such as osteoporosis, hepatitis, respiratory and gastrointestinal diseases. Its suite of products includes capsules, syringes, injection medicines, and solvents.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.03 | |||||
| Equity-to-Asset | 0.63 | |||||
| Debt-to-Equity | 0.45 | |||||
| Debt-to-EBITDA | 3.11 | |||||
| Interest Coverage | 4.63 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 2.65 | |||||
| Beneish M-Score | -2.34 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 5.7 | |||||
| 3-Year EBITDA Growth Rate | -4.1 | |||||
| 3-Year EPS without NRI Growth Rate | -12.2 | |||||
| 3-Year FCF Growth Rate | -20.4 | |||||
| 3-Year Book Growth Rate | 6.2 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 50.28 | |||||
| 9-Day RSI | 48.22 | |||||
| 14-Day RSI | 46.02 | |||||
| 6-1 Month Momentum % | -9.28 | |||||
| 12-1 Month Momentum % | -10.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.01 | |||||
| Quick Ratio | 0.46 | |||||
| Cash Ratio | 0.03 | |||||
| Days Inventory | 158.5 | |||||
| Days Sales Outstanding | 73 | |||||
| Days Payable | 31.47 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 4.03 | |||||
| Dividend Payout Ratio | 0.5 | |||||
| Forward Dividend Yield % | 4.03 | |||||
| 5-Year Yield-on-Cost % | 4.03 | |||||
| 3-Year Average Share Buyback Ratio | -1.3 | |||||
| Shareholder Yield % | -2.65 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 39.94 | |||||
| Operating Margin % | 7.01 | |||||
| Net Margin % | 6.88 | |||||
| FCF Margin % | -4.24 | |||||
| ROE % | 7.47 | |||||
| ROA % | 4.8 | |||||
| ROIC % | 6.59 | |||||
| ROC (Joel Greenblatt) % | 7.21 | |||||
| ROCE % | 7.28 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 12.83 | |||||
| PE Ratio without NRI | 12.42 | |||||
| Shiller PE Ratio | 8.76 | |||||
| PS Ratio | 0.88 | |||||
| PB Ratio | 0.96 | |||||
| Price-to-Tangible-Book | 1.03 | |||||
| Price-to-Operating-Cash-Flow | 30.34 | |||||
| EV-to-EBIT | 17.09 | |||||
| EV-to-EBITDA | 9.66 | |||||
| EV-to-Revenue | 1.26 | |||||
| EV-to-FCF | -29.67 | |||||
| Price-to-Projected-FCF | 1.77 | |||||
| Price-to-Median-PS-Value | 0.62 | |||||
| Price-to-Graham-Number | 0.76 | |||||
| Earnings Yield (Greenblatt) % | 5.85 | |||||
| FCF Yield % | -4.89 | |||||
| Forward Rate of Return (Yacktman) % | -18.63 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Samjin Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 292,128.534 | ||
| EPS (TTM) (â‚©) | 1544 | ||
| Beta | 0.15 | ||
| Volatility % | 9.72 | ||
| 14-Day RSI | 46.02 | ||
| 14-Day ATR (â‚©) | 208.642867 | ||
| 20-Day SMA (â‚©) | 19791 | ||
| 12-1 Month Momentum % | -10.29 | ||
| 52-Week Range (â‚©) | 19370 - 25000 | ||
| Shares Outstanding (Mil) | 12.77 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Samjin Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Samjin Pharmaceutical Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Samjin Pharmaceutical Co Ltd Frequently Asked Questions
What is Samjin Pharmaceutical Co Ltd(XKRX:005500)'s stock price today?
The current price of XKRX:005500 is â‚©19830.00. The 52 week high of XKRX:005500 is â‚©25000.00 and 52 week low is â‚©19370.00.
When is next earnings date of Samjin Pharmaceutical Co Ltd(XKRX:005500)?
The next earnings date of Samjin Pharmaceutical Co Ltd(XKRX:005500) is .
Does Samjin Pharmaceutical Co Ltd(XKRX:005500) pay dividends? If so, how much?
The Dividend Yield %  of Samjin Pharmaceutical Co Ltd(XKRX:005500) is 4.03% (As of Today), Highest Dividend Payout Ratio of Samjin Pharmaceutical Co Ltd(XKRX:005500) was 0.81. The lowest was 0.27. And the median was 0.35. The  Forward Dividend Yield % of Samjin Pharmaceutical Co Ltd(XKRX:005500) is 4.03%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers